AGP Picks
View all

The Boston Examiner
Provided by AGP

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 22, 2026

Global Vaccine Adjuvants Market to Reach $3.1 Billion by 2031, Driven by Next-Generation Vaccine Platform Development
Sep. 22, 2026

Global Vaccine Adjuvants Market to Reach $3.1 Billion by 2031, Driven by Next-Generation Vaccine Platform Development

Indeterminate GlobeNewswire
Growth in Enterprise AI Adoption is Driving Copyright Risk, According to New Study from CCC and Outsell
Sep. 22, 2026

Growth in Enterprise AI Adoption is Driving Copyright Risk, According to New Study from CCC and Outsell

Indeterminate GlobeNewswire
Rendever Expands Dementia & Empathy Training With a New Mode for Family Caregivers
Sep. 22, 2026

Rendever Expands Dementia & Empathy Training With a New Mode for Family Caregivers

Indeterminate GlobeNewswire
New Cangrade Research Shows HR Has Been Wrong About Gen Z and Millennials for Two Decades
Sep. 22, 2026

New Cangrade Research Shows HR Has Been Wrong About Gen Z and Millennials for Two Decades

Indeterminate GlobeNewswire
MDaudit to Collaborate with Healthcare Finance Leaders During NAHRI’s Revenue Integrity Leadership Exchange
Sep. 22, 2026

MDaudit to Collaborate with Healthcare Finance Leaders During NAHRI’s Revenue Integrity Leadership Exchange

Indeterminate GlobeNewswire
Fall Savings Arrive at Stop & Shop with FREE Cold Brew Coffee, New Value-Focused Meal Solutions and the Return of Dollar Deals
Sep. 22, 2026

Fall Savings Arrive at Stop & Shop with FREE Cold Brew Coffee, New Value-Focused Meal Solutions and the Return of Dollar Deals

Indeterminate GlobeNewswire
ATI and Elsevier Obtain Preliminary Injunction Against Naxlex in Nursing Assessment Piracy and Cheating Case
Sep. 22, 2026

ATI and Elsevier Obtain Preliminary Injunction Against Naxlex in Nursing Assessment Piracy and Cheating Case

Indeterminate GlobeNewswire
Advisor360° Wins 2026 Wealth Management Industry Award for Practice Intelligence
Sep. 22, 2026

Advisor360° Wins 2026 Wealth Management Industry Award for Practice Intelligence

Indeterminate GlobeNewswire
Bevi® Enters the Better-for-You Soda, Sports, and Energy Drink Markets with BeviPop™
Sep. 22, 2026

Bevi® Enters the Better-for-You Soda, Sports, and Energy Drink Markets with BeviPop™

Indeterminate GlobeNewswire
New Publication Associates SherpaPak® Cardiac Transport System with Lower Costs Across Heart Transplant Care
Sep. 22, 2026

New Publication Associates SherpaPak® Cardiac Transport System with Lower Costs Across Heart Transplant Care

Indeterminate GlobeNewswire
Cynet Announces Version 5.0 of its Platform, Unveiling New Cross-Site Dashboard and Enhanced SIEM Capabilities to Maximize Speed, Scale, and Interoperability
Sep. 22, 2026

Cynet Announces Version 5.0 of its Platform, Unveiling New Cross-Site Dashboard and Enhanced SIEM Capabilities to Maximize Speed, Scale, and Interoperability

Indeterminate GlobeNewswire
Rocket Software Named as a Major Player in IDC MarketScape® for Intelligent Content Services
Sep. 22, 2026

Rocket Software Named as a Major Player in IDC MarketScape® for Intelligent Content Services

Indeterminate GlobeNewswire
Compass Therapeutics Provides Regulatory Update on Tovecimig in Biliary Tract Cancer Following FDA Feedback
Sep. 22, 2026

Compass Therapeutics Provides Regulatory Update on Tovecimig in Biliary Tract Cancer Following FDA Feedback

Indeterminate GlobeNewswire
VistaShares Introduces the Shield Family of ETFs, Providing The Better Buffer Advisors and Investors Have Been Seeking
Sep. 22, 2026

VistaShares Introduces the Shield Family of ETFs, Providing The Better Buffer Advisors and Investors Have Been Seeking

Indeterminate GlobeNewswire
Levi Strauss & Co. and Marks & Spencer launch the Fashion Renewable Collaborative to turn climate commitments into renewable electricity action
Sep. 22, 2026

Levi Strauss & Co. and Marks & Spencer launch the Fashion Renewable Collaborative to turn climate commitments into renewable electricity action

Indeterminate GlobeNewswire
Medera Expands Singapore Presence Through Partnership with National Heart Centre Singapore
Sep. 22, 2026

Medera Expands Singapore Presence Through Partnership with National Heart Centre Singapore

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 years of Age and Older with Acquired Hypothalamic Obesity
Sep. 22, 2026

Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 years of Age and Older with Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire
NIS + Proteos Unite as TrueCourse Biosciences as Demand Surges for Wet-Lab Validation of AI-Designed Drugs
Sep. 22, 2026

NIS + Proteos Unite as TrueCourse Biosciences as Demand Surges for Wet-Lab Validation of AI-Designed Drugs

Indeterminate GlobeNewswire
Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs
Sep. 22, 2026

Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs

Indeterminate GlobeNewswire
Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365
Sep. 22, 2026

Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.